132 related articles for article (PubMed ID: 38663779)
1. Dan-shen Yin promotes bile acid metabolism and excretion to prevent atherosclerosis via activating FXR/BSEP signaling pathway.
Sheng Y; Meng G; Zhang M; Chen X; Chai X; Yu H; Han L; Wang Q; Wang Y; Jiang M
J Ethnopharmacol; 2024 Aug; 330():118209. PubMed ID: 38663779
[TBL] [Abstract][Full Text] [Related]
2. PARP-1 inhibitor alleviates liver lipid accumulation of atherosclerosis
Sheng Y; Meng G; Zhou Z; Du R; Wang Y; Jiang M
Mol Omics; 2023 Aug; 19(7):560-573. PubMed ID: 37249474
[No Abstract] [Full Text] [Related]
3. Dolomiaea souliei ethyl acetate extract protected against α-naphthylisothiocyanate-induced acute intrahepatic cholestasis through regulation of farnesoid x receptor-mediated bile acid metabolism.
Meng F; Zong W; Wei X; Tao Y; Wang G; Liao Z; Chen M
Phytomedicine; 2021 Jul; 87():153588. PubMed ID: 34091148
[TBL] [Abstract][Full Text] [Related]
4. Alisol B 23-acetate adjusts bile acid metabolisim via hepatic FXR-BSEP signaling activation to alleviate atherosclerosis.
Fu Y; Feng H; Ding X; Meng QH; Zhang SR; Li J; Chao Y; Ji TT; Bi YH; Zhang WW; Chen Q; Zhang YH; Feng YL; Bian HM
Phytomedicine; 2022 Jul; 101():154120. PubMed ID: 35523117
[TBL] [Abstract][Full Text] [Related]
5. Heterozygous knockout of Bile salt export pump ameliorates liver steatosis in mice fed a high-fat diet.
Okushin K; Tsutsumi T; Ikeuchi K; Kado A; Enooku K; Fujinaga H; Yamauchi N; Ushiku T; Moriya K; Yotsuyanagi H; Koike K
PLoS One; 2020; 15(8):e0234750. PubMed ID: 32785220
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of cholesterol 7α-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis.
Li T; Matozel M; Boehme S; Kong B; Nilsson LM; Guo G; Ellis E; Chiang JY
Hepatology; 2011 Mar; 53(3):996-1006. PubMed ID: 21319191
[TBL] [Abstract][Full Text] [Related]
7. Polymethoxyflavones in citrus extract has a beneficial effect on hypercholesterolemia rats by promoting liver cholesterol metabolism.
Du Y; Su J; Yan M; Wang Q; Wang T; Gao S; Tian Y; Wang Y; Chen S; Lv G; Yu J
J Ethnopharmacol; 2024 Mar; 322():117644. PubMed ID: 38135227
[TBL] [Abstract][Full Text] [Related]
8. The effect of ursodeoxycholic acid on the relative expression of the lipid metabolism genes in mouse cholesterol gallstone models.
Fan N; Meng K; Zhang Y; Hu Y; Li D; Gao Q; Wang J; Li Y; Wu S; Cui Y
Lipids Health Dis; 2020 Jul; 19(1):158. PubMed ID: 32615989
[TBL] [Abstract][Full Text] [Related]
9. Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor.
Li T; Xu L; Zheng R; Wang X; Li L; Ji H; Hu Q
Phytomedicine; 2020 Mar; 68():153153. PubMed ID: 32018210
[TBL] [Abstract][Full Text] [Related]
10. Pectin penta-oligogalacturonide reduces cholesterol accumulation by promoting bile acid biosynthesis and excretion in high-cholesterol-fed mice.
Zhu RG; Sun YD; Hou YT; Fan JG; Chen G; Li TP
Chem Biol Interact; 2017 Jun; 272():153-159. PubMed ID: 28549616
[TBL] [Abstract][Full Text] [Related]
11. Network pharmacology-based mechanism prediction and pharmacological validation of Xiaoyan Lidan formula on attenuating alpha-naphthylisothiocyanate induced cholestatic hepatic injury in rats.
Wang M; Liu F; Yao Y; Zhang Q; Lu Z; Zhang R; Liu C; Lin C; Zhu C
J Ethnopharmacol; 2021 Apr; 270():113816. PubMed ID: 33444723
[TBL] [Abstract][Full Text] [Related]
12. Dietary fat and gut microbiota interactions determine diet-induced obesity in mice.
Kübeck R; Bonet-Ripoll C; Hoffmann C; Walker A; Müller VM; Schüppel VL; Lagkouvardos I; Scholz B; Engel KH; Daniel H; Schmitt-Kopplin P; Haller D; Clavel T; Klingenspor M
Mol Metab; 2016 Dec; 5(12):1162-1174. PubMed ID: 27900259
[TBL] [Abstract][Full Text] [Related]
13. Da-Huang-Xiao-Shi decoction protects against3, 5-diethoxycarbonyl-1,4-dihydroxychollidine-induced chronic cholestasis by upregulating bile acid metabolic enzymes and efflux transporters.
Xue H; Fang S; Zheng M; Wu J; Li H; Zhang M; Li Y; Wang T; Shi R; Ma Y
J Ethnopharmacol; 2021 Apr; 269():113706. PubMed ID: 33346024
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic activation of hepatic farnesoid X receptor prevents parenteral nutrition-associated cholestasis in mice.
El Kasmi KC; Ghosh S; Anderson AL; Devereaux MW; Balasubramaniyan N; D'Alessandro A; Orlicky DJ; Suchy FJ; Shearn CT; Sokol RJ
Hepatology; 2022 Feb; 75(2):252-265. PubMed ID: 34387888
[TBL] [Abstract][Full Text] [Related]
15. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G
Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of hepatic farnesoid X receptor by FGF19 signaling-activated Src maintains cholesterol levels and protects from atherosclerosis.
Byun S; Jung H; Chen J; Kim YC; Kim DH; Kong B; Guo G; Kemper B; Kemper JK
J Biol Chem; 2019 May; 294(22):8732-8744. PubMed ID: 30996006
[TBL] [Abstract][Full Text] [Related]
17. Trimethylamine-N-oxide (TMAO)-induced atherosclerosis is associated with bile acid metabolism.
Ding L; Chang M; Guo Y; Zhang L; Xue C; Yanagita T; Zhang T; Wang Y
Lipids Health Dis; 2018 Dec; 17(1):286. PubMed ID: 30567573
[TBL] [Abstract][Full Text] [Related]
18. Puerarin Modulates Hepatic Farnesoid X Receptor and Gut Microbiota in High-Fat Diet-Induced Obese Mice.
Yang CW; Liu HM; Chang ZY; Liu GH; Chang HH; Huang PY; Lee TY
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791314
[TBL] [Abstract][Full Text] [Related]
19. Dehydrodiconiferyl alcohol, a lignan from Herpetospermum pedunculosum, alleviates cholestasis by activating pathways associated with the farnesoid X receptor.
Wei X; Ma Y; Dong Z; Wang G; Lan X; Liao Z; Chen M
Phytomedicine; 2021 Jan; 80():153378. PubMed ID: 33113499
[TBL] [Abstract][Full Text] [Related]
20. Bile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinoma.
Chen Y; Song X; Valanejad L; Vasilenko A; More V; Qiu X; Chen W; Lai Y; Slitt A; Stoner M; Yan B; Deng R
Hepatology; 2013 Apr; 57(4):1530-41. PubMed ID: 23213087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
